|
|
|
Press Release: Tenth International Pharma Compliance Congress Features Anticorruption Investigations Case Study
|
- A Hybrid Conference and Internet Event
- Sponsored by ETHICS, the International Society of Healthcare Compliance Professionals
- Co-sponsored by the Pharmaceutical Compliance Forum
- May 10 - 12, 2016
- Onsite at the Hilton Warsaw Hotel and Convention Centre in Warsaw, Poland
- In Your Own Office or Home live via the Internet with 24/7 Access for Six Months
- www.InternationalPharmaCongress.com
PRESS RELEASE
Phone: 800-503-8171
Email: registration@hcconferences.com
Website: www.InternationalPharmaCongress.com
|
|
FEATURING AN ANTICORRUPTION INVESTIGATIONS CASE STUDY BY
|
Pierre E. Dupourque, JD
Assistant General Counsel, Regional Compliance Lead EMEA, Canada, Pakistan, India, Pfizer, Mannheim, Germany |
Vivian Robinson, Esq.
Queen's Counsel, Partner, McGuire Woods, Former General Counsel of the UK Serious Fraud Office, Former Head, QEB Hollis Whiteman Chambers, Recorder of the Crown Court and Treasurer of Inner Temple, London, UK |
Daniel Schafaghi
Corporate Ethics and Compliance, Boehringer Ingelheim GmbH, Ingelheim, Germany
|
Ashley Watson, Esq.
Senior Vice President, Chief Ethics and Compliance Officer, Merck & Co, Inc., Former Counsel, Chief Ethics and Compliance Officer, Hewlett-Packard, Philadelphia, PA, USA |
Gary Giampetruzzi, Esq.
Partner, Paul Hastings, Former Vice President and Assistant General Counsel, and Head, Government Investigations, Pfizer Inc., Washington, DC, USA (Moderator)
|
|
|
|
WARSAW, POLAND -- PHARMA UPDATE NEWS SERVICE™ -- JANUARY 27, 2016: The Tenth International Pharmaceutical Compliance Congress, www.InternationalPharmaCongress.com, to be held on May 10 - 12, 2016 at the Hilton Warsaw Hotel and Convention Centre in Warsaw, Poland, today announced the conference dates and a call for presentation proposals.
|
|
KEYNOTE SPEAKERS
|
Sadek Beloucif, MD
Professor, Department of Anesthesiology and Critical Care Medicine, Avicenne University Hospital, Chairman, Ethics Committee of the Biomedicine Agency, Paris, France |
Hui Chen, JD
Compliance Counsel Expert, US Department of Justice, Former Global Head, Anti-Bribery and Corruption, Standard Chartered Bank, Former Assistant General Counsel, Pfizer, Washington, DC, USA |
Peter Dieners, Esq.
Partner and Head, Global Healthcare and Life Sciences Group, Clifford Chance, Co-chair, Legal Affairs Focus Group (LA FG), EUCOMED, Co-chair, Compliance Network (CN), EUCOMED, Düsseldorf, Germany
|
Gejaa Gobena, JD
Chief, Health Care Fraud Unit, US Department of Justice, Washington, DC, USA |
Jose F. Zamarriego Izquierdo
Director Unidad de Supervision Deontologica, FARMAINDUSTRIA, Madrid, Spain |
Dr. Grzegorz Makowski, PhD
Director of the Public Integrity Program, Stefan Batory Foundation, the Transparency International Chapter in Poland, Assistant Professor, Collegium Civitas, Warsaw, Poland
|
Sophie Peresson
Director, Pharmaceuticals & Healthcare Programme, Transparency International UK, London, UK |
Marie-Claire Pickaert
Deputy Director General and Chief Financial Officer, European Federation of Pharmaceutical Industries and Associations (EFPIA), Brussels, Belgium |
Heather Simmonds
Director, Prescription Medicines Code of Practice Authority; Vice-Chair, IFPMA Code Compliance Network, London, UK
|
|
|
|
CHIEF COMPLIANCE OFFICER ROUNDTABLE
|
Dante Beccaria
Global Compliance Officer and Vice President, Sanofi, Former Vice President of Internal Audit, Sanofi, Paris, France |
Eric Cornut, LLM
Chief Ethics, Compliance & Policy Officer, Novartis, Former Chief Commercial Officer, Novartis, Basel, Switzerland |
Martin Fürle, MBA (Berlin)
General Counsel and Chief Compliance Officer, Vice President Risk & Compliance, Daiichi Sankyo Europe GmbH, Munich, Germany
|
Marc-Olivier Lamaro
Chief Compliance Officer, Sanofi Pasteur MSD, Former Director, Compliance Officer, Johnson & Johnson, Lyon, France |
Lori V. Queisser
Senior Vice President and Global Compliance Officer, Teva Pharmaceuticals, Former Sr. VP Global Compliance and Business Practices, Schering-Plough, Former Vice President and Chief Compliance Officer, Eli Lilly, Philadelphia, PA, USA |
Uffe Kåre Rasmussen, M.Sc.
Senior Director and Chief Compliance Officer, H. Lundbeck A/S, Former Principal Scientist, Novo Nordisk A/S, Copenhagen, Denmark
|
Ashley Watson, Esq.
Senior Vice President, Chief Ethics & Compliance Officer, Merck, Inc., Former Counsel, Chief Ethics and Compliance Officer, Hewlett-Packard, Philadelphia, PA, USA |
Kip Ebel, MBA
Principal, Fraud Investigation & Dispute Services, EY, New York, NY, USA (Moderator)
|
|
|
|
GLOBAL ANTICORRUPTION UPDATE
|
Ted Acosta, Esq.
Americas Vice Chair, Risk Management and Global Leader, Life Sciences, Fraud Investigation and Dispute Services, EY, Former Senior Counsel, Office of Inspector General, US Department of Health and Human Services, New York, NY, USA and Paris, France |
Cristian Ducu, PhD
Founder and General Manager, Centre for Advanced Research in Management and Applied Ethics, Member, National Bioethics Commission of the National Commission of Romania for UNESCO, Founding Member, Research Centre in Applied Ethics, Faculty of Philosophy, University of Bucharest, Bucharest, Romania |
Gary F. Giampetruzzi, Esq.
Partner, Paul Hastings, Former Vice President and Assistant General Counsel, Head of Government Investigations, Pfizer Inc., New York, NY, USA
|
Michael K. Loucks, Esq.
Partner, Skadden Arps LLP, Former Acting United States Attorney, District of Massachusetts, United States Department of Justice, Washington, DC, USA |
Paul J. Melling, Esq.
Founding Partner, Baker & McKenzie - CIS, Limited, Moscow, Russia |
Vivian Robinson, Esq.
Queen's Counsel, Partner, McGuire Woods, Former General Counsel of the UK Serious Fraud Office, Former Head, QEB Hollis Whiteman Chambers, Recorder of the Crown Court and Treasurer of Inner Temple, London, UK
|
|
|
|
FEATURED FACULTY
|
Marc Bartel, LLM, MBA
Managing Partner France, Partner, Legal and Board Practices, Heidrick & Struggles, Paris, France |
Andy Bender, MS, MBA
President and Founder, Polaris, New York, NY |
Olivier Chaduteau
Managing Partner, Day One, Mentor for Entrepreneurs, IME (French Chamber of Commerce), Lecturer, Sciences Po Law School, Paris, France
|
Pierre E. Dupourque, JD
Assistant General Counsel, Regional Compliance Lead EMEA, Canada, Pakistan, India, Pfizer, Mannheim, Germany |
Sue Egan
Director and Principal Consultant, Sue Egan Associates, Former Vice President Compliance, AstraZeneca, Great Missenden, Buckinghamshire, UK |
Cécile Gousset
Associate Vice President, Compliance Risk Assessment, Education and Monitoring, Global Ethics & Business Integrity, Sanofi, Paris, France
|
Isaure Kergall-Gayet
Compliance and Business Integrity Director France, Sanofi, Members, Strategic Committee, ETHICS, Former Vice President, Chief Ethics and Compliance Officer, Ipsen, Paris, France |
Keith M. Korenchuk, JD, MPH
Partner, Arnold & Porter LLP, Washington, DC |
Tomasz Kruk, MBA, LLM
Head of Compliance, Vifor Pharma, Former Director International Compliance, Mallinckrodt Pharmaceuticals, Former Director Global Ethics & Compliance, Actavis plc (now Allergan plc), Zürich, Switzerland
|
Evelyne Lemaire, MA
Head of Compliance, Europe & Canada, Takeda Pharmaceuticals International GmbH, Zurich, Switzerland |
Christine Longawa, CPA, CFE
Associate Director, Healthcare & Life Sciences Disputes, Regulatory, Compliance and Investigations, Navigant Consulting, Inc.. Chicago, IL, USA |
Maurits J.F. Lugard, MA, JD, LLM
Partner and Lead, EU Life Sciences Regulatory Team, Sidley Austin LLP, Former Member of the European Commission's Legal Service, Brussels, Belgium
|
Abdul Luheshi, MBA
Director, Life-Sciences, Regulatory Compliance, KPMG UK LLP, Former Vice President, Health Care Compliance, Johnson & Johnson, Former Co-chair, Asia Pacific Pharma Compliance Congress, London, UK |
Daniela Fabian Masoch, Esq.
Founder and Managing Director, Fabian Privacy Legal GmbH, Member and Chapter Co-Chair, International Privacy Professionals Association (IAPP), Former Global Head Data Privacy, Novartis International AG, Basel, Switzerland |
John Patrick Oroho, Esq.
Executive Vice President and Chief Strategy Officer, Porzio Life Sciences, LLC, Principal, Porzio, Bromberg & Newman PC, Morristown, NJ, USA
|
David O'Shaughnessy
Vice President, Compliance, Emerging Markets, Quintiles, Board Member, ETHICS, Former Vice President Compliance, International Pharmaceuticals, GSK, Former Vice President, Global Compliance Strategy, AstraZeneca, Reading, UK |
Piergiorgio Pepe, LLB
EEMEA Director, Ethics and Compliance, AbbVie, Former Director, Compliance and Ethics, EMEA, Bristol-Myers Squibb, Paris Area, France |
Nathalie Raynaud
Corporate Compliance Officer, Ethics & Business Integrity Department, Sanofi, Paris, France
|
Daniel Schafaghi
Corporate Ethics and Compliance, Boehringer Ingelheim GmbH, Ingelheim, Germany |
Michele Tagliaferri, Esq.
Partner, Sidley Austin LLP, Brussels, Belgium |
Dr. Mirjam Weisse, JD
Senior Director, Head of Compliance EMEA, Merz Pharma GmbH & Co, KGaA, Frankfurt, Germany
|
Andrew White
Head of Medicine Management - NHS, Greater Manchester Commissioning Support Unit, Manchester, UK |
Mariusz Witalis
Partner, Fraud Investigation and Dispute Services, Ernst & Young LLP, Warsaw, Poland |
Olivier Wong
Consultant, Early Engagement, HTA Technology Transfer, MediQualité Omega, Former Voting Member, French Transparency Committee, Former French Guidelines Committee Member (HAS, ANSM), Paris, France
|
Elisabethann Wright, Esq.
Partner, Hogan Lovells, Former Senior Legal Officer and Hearing Officer, EFTA Surveillance Authority, Brussels, Belgium |
Jolanta Wyszynska
Vice President Compliance Europe, AstraZeneca, Warsaw, Poland
|
Ghadeer Al Yacoub
Regional Health Care Compliance Officer Turkey, Middle East, Africa, Johnson & Johnson, Head, ETHICS Chapter for MEA, Dubai, UAE |
Milena Yakimova, LLM
Director Ethics & Compliance, Central and South East Europe, Allergan, Sofia, Bulgaria
|
|
|
|
|
|
SPEAKER PRESENTATION PROPOSALS
|
Speaker/Presentation Proposals for the International Pharma Congress May Be Submitted Through Our Online Form
- Click Here -
|
|
|
|
SPONSORED BY:
|
|
|
CO-SPONSORS:
|
|
|
CO CHAIRS
|
Dr. Michael Bartke
Director Compliance Management, DAIICHI SANKYO EUROPE GmbH, Munich, Germany
|
Ann Beasley
Chief Compliance Officer, Biogen, Former Global Compliance Officer, Novartis Pharma AG, Board Member and Co-chair, Strategic Committee International Society of Healthcare, Ethics, and Compliance Professionals (ETHICS), Cambridge, MA, USA
|
Stephen Nguyen Duc
Office of Ethics & Compliance Area Director, International Operations, Western Europe & Canada, AbbVie, Rungis, France
|
Dominique Laymand, Esq.
Senior Vice President, Chief Ethics and Compliance Officer, Ipsen; President, International Society of Healthcare Ethics and Compliance Professionals (ETHICS), Paris, France
|
Roeland Van Aelst
Regional Vice President - HCCO MD&D EMEA & Canada, Office Health Care Compliance and Privacy, Johnson & Johnson, Co-chair, Strategic Committee, International Society of Healthcare, Ethics and Compliance Professionals (ETHICS), Chairman, MedTech Compliance Network, Brussels, Belgium
|
|
GRANTORS:
|
|
DIAMOND
|
|
|
BRONZE
|
|
|
FOLLOW INTERNATIONAL PHARMA CONGRESS ON
|
Tweet using #PharmaCongress
|
|
PARTICIPATION OPTIONS
|
|
|
|
TRADITIONAL ONSITE ATTENDANCE
|
Simply register, travel to the conference city and attend in person.
Pros: subject matter immersion; professional networking opportunities; faculty interaction
|
|
LIVE AND ARCHIVED WEBCAST PARTICIPATION
|
Watch the conference in live streaming video over the Internet and at your convenience at any time 24/7 for the six months following the event.
The archived conference includes speaker videos and coordinated PowerPoint presentations.
Pros: Live digital feed and 24/7 Internet access for next six months; Accessible in office, at home or anywhere worldwide with Internet access; Avoid travel expense and hassle; No time away from the office
|
WEBCAST INTERFACE SAMPLE
|
Click here for a sample stream
|
|
 This site complies with the HONcode standard for trustworthy health information:
verify here.
|
|
|
2016 GLOBAL PHARMA COMPLIANCE CONGRESSES
|
|
SEVENTEENTH PHARMACEUTICAL REGULATORY AND COMPLIANCE CONGRESS
|
A Hybrid Conference and Internet Event
Transformational Learning - Effective Knowledge Exchange
Sponsored by Pharmaceutical Compliance Forum
Media Partners: Harvard Health Policy Review, Health Affairs and Life Sciences Compliance Update
October 19 - 21, 2016
Mandarin Oriental
Washington, DC
www.PharmaCongress.com
|
|
SIXTH ASIA PACIFIC
PHARMACEUTICAL
COMPLIANCE CONGRESS
|
A Hybrid Conference and Internet Event
Sponsored by Asia Pacific Healthcare Industry Compliance Team
Cosponsored by International Society of Healthcare Ethics and Compliance Professionals (ETHICS) and Pharmaceutical Compliance Forum (PCF)
Media Partners: Life Sciences Compliance Update
September 21 - 23, 2016
Shangri-La Hotel
Singapore
www.AsianPharmaCongress.com
|
|
PHARMACEUTICAL SUMMIT ON BUSINESS AND COMPLIANCE ISSUES IN MANAGED MARKETS
|
The Leading Forum on Pharmaceutical Market Access, Reimbursement, Pricing, and Contracting with Commercial and Government Payers
Co-located with Eighth National Medical Home, Sixth Bundled Payment Summit and Seventh National ACO Summit
Media Partners: Harvard Health Policy Review, Health Affairs and Life Sciences Compliance Update
June 8 - 9, 2016
Grand Hyatt
Washington, DC
www.PharmaManagedMarketsSummit.com
|
|
|
FOR E-MAIL ADDRESS CHANGE, ADD OR DELETE REQUESTS
|
For changes or additions, please email your request to: listmgr@PharmaUpdateNewsService.com.
For removal of your e-mail address, please click the link below for "SafeUnsubscribe" to automatically remove your address from the list.
|
|
|
|
|
|
